Global Radiopharmaceuticals Market 2017-2021


◆タイトル:Global Radiopharmaceuticals Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥367,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥525,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。


当調査レポートでは、放射性医薬品の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、放射性医薬品の世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は放射性医薬品の世界市場が2017-2021年期間中に年平均9.02%成長すると予測しています。当レポート上に記載されている主な企業は• Bayer, • Cardinal Health, • GE Healthcare, • Lantheus Medical Imaging等です。

About RadiopharmaceuticalsRadiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.

Technavio’s analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bayer,
• Cardinal Health,
• GE Healthcare,
• Lantheus Medical Imaging

[Other prominent vendors]
• ABT Molecular Imaging
• Advanced Accelerator Applications
• Algeta
• Eczacibasi-Monrol Nuclear Products
• FUJIFILM Holdings
• Isologic Innovative Radiopharmaceuticals
• Nordion
• Piramal Imaging
• RadioMedix
• Triad Isotopes

[Market driver]
• Rising burden of the neurological disorders
• For a full, detailed list, view our report

[Market challenge]
• Shortage of radioisotopes
• For a full, detailed list, view our report

[Market trend]
• Partnerships for development of radiopharmaceuticals
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Pipeline analysis

PART 07: Market segmentation by application
• Diagnostics
• Therapeutics

PART 08: Geographical segmentation
• Radiopharmaceuticals market in Americas
• Radiopharmaceutical market in EMEA
• Radiopharmaceuticals market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Partnerships for development of radiopharmaceuticals
• Production based on cyclotron

PART 12: Vendor landscape

PART 13: Key vendor analysis
• Bayer
• Cardinal Health
• GE Healthcare
• Lantheus Medical Imaging
• Other prominent members

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Characteristics of radiopharmaceuticals
Exhibit 02: Factors affecting the development of new radiopharmaceutical
Exhibit 03: Applications of radiopharmaceuticals
Exhibit 04: Advantages and disadvantages of radiopharmaceuticals
Exhibit 05: Global radiopharmaceuticals market snapshot
Exhibit 06: Global radiopharmaceuticals market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis in global radiopharmaceuticals market
Exhibit 08: Five forces analysis
Exhibit 09: Key pipeline molecules by vendors
Exhibit 10: Key clinical trials
Exhibit 11: Segmentation of global radiopharmaceuticals market by application 2016
Exhibit 12: Segmentation of global radiopharmaceuticals market by application 2016 and 2021 (%)
Exhibit 13: Global radiopharmaceutical diagnostics market 2016-2021 ($ millions)
Exhibit 14: Diagnostic radiopharmaceuticals used in various clinical practices
Exhibit 15: Techniques of radiopharmaceutical imaging
Exhibit 16: Global radiopharmaceutical therapeutics market 2016-2021 ($ millions)
Exhibit 17: Commonly used radiopharmaceuticals for targeted radionuclide therapy
Exhibit 18: Treatment of tumors and cancers with radioisotopes
Exhibit 19: Segmentation of global radiopharmaceuticals market based on geography 2016 and 2021 (%)
Exhibit 20: Segmentation of global radiopharmaceuticals market revenue by geography 2016-2021 ($ millions)
Exhibit 21: Segmentation of global radiopharmaceuticals market share by geography 2016-2021 (%)
Exhibit 22: Market scenario in Americas
Exhibit 23: Radiopharmaceuticals market in Americas 2016-2021 ($ millions)
Exhibit 24: Radiopharmaceuticals market scenario in EMEA
Exhibit 25: Radiopharmaceuticals market in EMEA 2016-2021 ($ millions)
Exhibit 26: Radiopharmaceuticals market scenario in APAC
Exhibit 27: Radiopharmaceuticals market in APAC 2016-2021 ($ millions)
Exhibit 28: Functions of JRIA
Exhibit 29: Facts about the neurological disorders
Exhibit 30: Problems associated with the radiopharmaceutical drugs
Exhibit 31: Competitive structure analysis of the global pharmaceutical market 2016
Exhibit 32: Bayer: Key highlights
Exhibit 33: Bayer: Strength assessment
Exhibit 34: Bayer: Strategy assessment
Exhibit 35: Bayer: opportunity assessment
Exhibit 36: Cardinal Health: Key highlights
Exhibit 37: Cardinal Health: Strength assessment
Exhibit 38: Cardinal Health: Strategy assessment
Exhibit 39: Cardinal Health: Opportunity assessment
Exhibit 40: GE Healthcare: Key highlights
Exhibit 41: GE Healthcare: Strength assessment
Exhibit 42: GE Healthcare: Strategy assessment
Exhibit 43: GE Healthcare: Opportunity assessment
Exhibit 44: Lantheus Medical Imaging: Key highlights
Exhibit 45: Lantheus Medical Imaging: Strength assessment
Exhibit 46: Lantheus Medical Imaging: Strategy assessment
Exhibit 47: Lantheus Medical Imaging: Opportunity assessment


Bayer, Cardinal Health, GE Healthcare, Lantheus Medical Imaging, ABT Molecular Imaging, Advanced Accelerator Applications, Algeta, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, Isologic Innovative Radiopharmaceuticals, Nordion, Piramal Imaging, RadioMedix, and Triad Isotopes.





★調査レポート[放射性医薬品の世界市場] (Global Radiopharmaceuticals Market 2017-2021 / IRTNTR14246)販売に関する免責事項
[放射性医薬品の世界市場] (Global Radiopharmaceuticals Market 2017-2021 / IRTNTR14246)についてEメールでお問い合わせ